BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3573800)

  • 1. Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
    Nalos PC; Kass RM; Gang ES; Fishbein MC; Mandel WJ; Peter T
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):904-12. PubMed ID: 3573800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-related postoperative adult respiratory distress syndrome.
    Greenspon AJ; Kidwell GA; Hurley W; Mannion J
    Circulation; 1991 Nov; 84(5 Suppl):III407-15. PubMed ID: 1934438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of amiodarone to postoperative complications of transthoracic implantation of automatic implantable cardioverter defibrillators.
    Calkins H; Bahu M; Shyr Y; Schork A; Bolling S; Kou W; Kirsch M; Morady F
    Panminerva Med; 1996 Jun; 38(2):89-97. PubMed ID: 8979740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
    Installe E; Schoevaerdts JC; Gadisseux P; Charles S; Tremouroux J
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):302-8. PubMed ID: 7453241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic.
    Sanoski CA; Schoen MD; Gonzalez RC; Avitall B; Bauman JL
    Pharmacotherapy; 1998; 18(6 Pt 2):146S-151S. PubMed ID: 9855347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose amiodarone-related complications after cardiac operations.
    Dimopoulou I; Marathias K; Daganou M; Prapas S; Stavridis G; Khoury M; Geroulanos S; Cokkinos DV
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):31-7. PubMed ID: 9240291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone lung toxicity: role of pulmonary function tests.
    Foresti V; Carini L; Lovagnini-Scher CA; Parisio E; Scolari N; Pozzi G; Clini V
    Int J Clin Pharmacol Res; 1987; 7(5):373-80. PubMed ID: 3667010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary toxicity associated with the use of amiodarone].
    López AM; Sánchez C; Palazzo JP; Visconti RJ
    Medicina (B Aires); 1986; 46(4):400-6. PubMed ID: 3574102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and secondary effects of chronic treatment with amiodarone].
    Fajuri A; Rodríguez JA; González R; Jalil J; García E; Molgo M; Soza M; Valenzuela P
    Rev Med Chil; 1993 May; 121(5):516-22. PubMed ID: 8272632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
    Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
    Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of severe amiodarone-induced pneumopathy using inhaled nitric oxide].
    Fellahi JL; Texereau J; Chironi G; Qanadli SD; Jardin F
    Rev Pneumol Clin; 1997; 53(4):210-2. PubMed ID: 9616822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation?
    Hawthorne HR; Wood MA; Stambler BS; Damiano RJ; Ellenbogen KA
    Pacing Clin Electrophysiol; 1993 Dec; 16(12):2241-9. PubMed ID: 7508601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and chemical assessment of thyroid function during therapy with amiodarone.
    Amico JA; Richardson V; Alpert B; Klein I
    Arch Intern Med; 1984 Mar; 144(3):487-90. PubMed ID: 6703817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.